Mea Hana Embolization Vascular Polyvinyl Alcohol Embolic Microspheres
Nā Hōʻailona no ka Hoʻohana (E wehewehe)
Nā Microspheres Embolicua manaʻo ʻia e hoʻohana ʻia no ka embolization o nā arteriovenous malformations (AVMs) a me nā puʻupuʻu hypervascular, me nā fibroids uterine.
Inoa Maʻamau a Inoa Maʻamau paha:Nā Microspheres Embolic Polyvinyl AlcoholHoʻokaʻawale ʻana
Inoa:Mea Hana Embolization Vascular
Hoʻokaʻawale ʻana: Papa II
Papa:Ka maʻi ʻōnaehana cardiovascular
Wehewehena o ka hāmeʻa
ʻO nā Embolic Microspheres he mau microspheres hydrogel hiki ke hoʻopili ʻia me ke ʻano maʻamau, ka ʻili laumania, a me ka nui i hoʻoponopono ʻia, i hana ʻia ma muli o ka hoʻololi kemika ma nā mea polyvinyl alcohol (PVA). Aia nā Embolic Microspheres i kahi macromer i loaʻa mai ka polyvinyl alcohol (PVA), a he hydrophilic, non-resorbable, a loaʻa i nā ʻano nui like ʻole. ʻO ka hopena mālama he 0.9% sodium chloride solution. ʻO ka nui o ka wai o ka microsphere polymerized piha he 91% ~ 94%. Hiki i nā Microspheres ke ʻae i ka hoʻopili ʻana o 30%.
Hoʻolako ʻia nā Embolic Microspheres i sterile a hoʻopili ʻia i loko o nā ʻōmole aniani i hoʻopaʻa ʻia.
Ua manaʻo ʻia nā Embolic Microspheres e hoʻohana ʻia no ka embolization o nā arteriovenous malformations (AVMs) a me nā puʻupuʻu hypervascular, me nā fibroids uterine. Ma ka ālai ʻana i ke kahe koko i ka wahi i manaʻo ʻia, ua nele ka puʻupuʻu a i ʻole ka malformation i nā meaʻai a emi iho ka nui.
Hiki ke hāʻawi ʻia nā Embolic Microspheres ma o nā microcatheters maʻamau i ka pae 1.7-4 Fr. I ka manawa e hoʻohana ai, ua hui pū ʻia nā Embolic Microspheres me kahi mea hoʻohālikelike nonionic e hana i kahi hopena hoʻokuʻu. Ua manaʻo ʻia nā Embolic Microspheres no ka hoʻohana hoʻokahi a ua hāʻawi ʻia i sterile a non-pyrogenic. Ua wehewehe ʻia nā hoʻonohonoho ʻana o ka hāmeʻa o Embolic Microsphere ma ka Papa 1 a me ka Papa 2 ma lalo nei.
Ma waena o nā ʻano nui like ʻole o nā Embolic Microspheres, ʻo nā ʻano nui e hiki ke hoʻohana ʻia no ka uterine fibroid embolization he 500-700μm, 700-900μm a me 900-1200μm.
Table: Nā hoʻonohonoho hāmeʻa o nā Microspheres Embolic
Ihōʻike
Proʻauwai
Kōkuhi
Hoʻoponopono ʻia
Ka nui (µm)
Qnui
Hynā puʻupuʻu pervascular / Arteriovenous
Manā hoʻokumu ʻana
ʻO ka Fibroid Uterine
B107S103 100-300
1ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAʻole
B107S305 300-500
1ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAʻole
B107S507 500-700
1ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAe
B107S709 700-900
1ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAe
B107S912 900-1200
1ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAe
B207S103 100-300
2ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAʻole
B207S305 300-500
2ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAʻole
B207S507 500-700
2ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAe
B207S709 700-900
2ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAe
B207S912 900-1200
2ml microspheres: 7ml 0.9%
sodium chloride
ʻAe ʻAe
|
Proʻauwai Kōkuhi |
Hoʻoponopono ʻia Ka nui (µm) |
Qnui | Ihōʻike | |
| Hynā puʻupuʻu pervascular / Arteriovenous Manā hoʻokumu ʻana |
ʻO ka Fibroid Uterine | |||
| U107S103 | 100-300 | 1ml microspheres: 7ml 0.9% sodium chloride | ʻAe | No |
| U107S305 | 300-500 | 1ml microspheres: 7ml 0.9% sodium chloride | ʻAe | No |
| U107S507 | 500-700 | 1ml microspheres: 7ml 0.9% sodium chloride | ʻAe | ʻAe |
| U107S709 | 700-900 | 1ml microspheres: 7ml 0.9% sodium chloride | ʻAe | ʻAe |
| U107S912 | 900-1200 | 1ml microspheres: 7ml 0.9% sodium chloride | ʻAe | ʻAe |
| U207S103 | 100-300 | 2ml microspheres: 7ml 0.9% sodium chloride | ʻAe | No |
| U207S305 | 300-500 | 2ml microspheres: 7ml 0.9% sodium chloride | ʻAe | No |
| U207S507 | 500-700 | 2ml microspheres: 7ml 0.9% sodium chloride | ʻAe | ʻAe |
| U207S709 | 700-900 | 2ml microspheres: 7ml 0.9% sodium chloride | ʻAe | ʻAe |
| U207S912 | 900-1200 | 2ml microspheres: 7ml 0.9% sodium chloride | ʻAe | ʻAe |














